You searched for "safety"
ESCRS 2023: GLAUKOS Speakers Corner: Saturday 9 September
Join our Expert Panel throughout the day to learn more about the iStent inject WESCRS 2023: GLAUKOS Speakers Corner: Sunday 10 September
Join our Expert Panel throughout the day to learn more about the iStent inject W
Use of orthoK for myopia treatment
This article provides an updated literature review on the orthkeratology effect on myopia progression considering outcome measures, potential effect modifiers, mechanisms and current prescription concerns. The discussion centres on the extent of slowed myopia progression, mechanisms, safety concerns and comparisons...College of Optometrists publishes guidance on GLP-1 weight loss drugs and vision
GLP-1 weight loss drugs and vision: what clinicians need to know The College of Optometrists has issued guidance for clinicians following the publication of a recent MHRA drug safety update which has drawn attention to a very rare risk of...Has ‘reduce, reuse and recycle’ gone too far?
The past few decades of surgery since the ‘mad cow disease’ have been dominated by a push to switch to disposable instruments. The reason is to prevent cross-contamination and reduce the risk of surgical site infections – especially so with...
LASEK with mitomycin C to correct myopia in thin corneas
This study evaluated the long-term outcomes of laser-assisted subepithelial keratomileusis (LASEK) with intraoperative use of mitomycin C (MMC) performed on thin corneas for the correction of myopia. MMC modulates the corneal wound healing response in surface healing, thus reducing the...
Implantation of intraocular pressure sensor in glaucoma patients
The authors report safety and accuracy of an intraocular intraocular pressure (IOP) sensor placed in the ciliary sulcus during planned cataract surgery. Six patients underwent implantation of the device; a silicone rubber ring-shaped device encapsulating pressure sensitive capacitors and a...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...Glaukos at ESCRS 2025
The 2026 ESCRS meeting in Copenhagen was a highly successful and busy event for Glaukos, highlighted by the launch of iStent infinite®. The new device was prominently featured across podium presentations, booth speaker sessions, and hands-on dry labs, following its...
